Cargando…
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
Autores principales: | Cour, Martin, Ovize, Michel, Argaud, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265662/ https://www.ncbi.nlm.nih.gov/pubmed/32487139 http://dx.doi.org/10.1186/s13054-020-03014-1 |
Ejemplares similares
-
Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trial
por: Kreitmann, Louis, et al.
Publicado: (2020) -
Airway Closure and Expiratory Flow Limitation in Acute Respiratory Distress Syndrome
por: Guérin, Claude, et al.
Publicado: (2022) -
Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study
por: Cour, Martin, et al.
Publicado: (2021) -
Lung Recruitability Evaluated by Recruitment-to-Inflation Ratio and Lung Ultrasound in COVID-19 Acute Respiratory Distress Syndrome
por: Stevic, Neven, et al.
Publicado: (2021) -
Feasibility of non-invasive respiratory drive and breathing pattern evaluation using CPAP in COVID-19 patients
por: Dargent, Auguste, et al.
Publicado: (2022)